Eifion Phillips, Ph.D., J.D.
Patent Attorney
A medicinal chemistry scientist turned patent attorney, Dr. Eifion Phillips has helped secure his clients’ intellectual property portfolios across various fields and innovations...
Kanaga Sabapathy, Ph.D.
Head, Division of Cellular and Molecular Research, National Cancer Center Singapore
Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995.
Michael Salgaller, Ph.D.
Supervisory Invention Development & Marketing Specialist, National Institutes of Health/National Cancer Institute
Dr. Michael Salgaller leads the Invention Development and Marketing Unit within the National Cancer Institute’s Technology Transfer Center, where he…
Paul Schimmel, Ph.D.
Professor, Department of Cell and Molecular Biology, The Scripps Research Institute
Paul Schimmel, Ph.D., is a biophysical chemist and he received his B.A. in biochemistry and biophysics from Ohio Wesleyan University in 1962...
Fei Shen, Ph.D.
Managing Director, Boehringer Ingelheim Venture Fund USA
Fei is an Investment Director in the Boehringer Ingelheim Corporate Venture Fund. She joined the Boehringer Ingelheim Venture Fund in…
Ashim Subedee, Ph.D.
Academic Innovation Lead, National Institutes of Health
Dr. Subedee currently serves as Program Director at the National Cancer Institute Small Business Innovation Research(SBIR) Development Center...
Thea Tlsty, Ph.D.
Professor of Pathology, University of California San Francisco
Dr. Thea Tlsty is Professor of Pathology at the University of California, San Francisco. She is known for her research…
Daniel D. Von Hoff M.D., F.A.C.P.
Physician-in-Chief & Distinguished Professor, Translational Genomics Research Institute
Daniel D. Von Hoff, M.D., F.A.C.P. FASCO, FAACR is currently Physician in Chief, Distinguished Professor at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona.
Barbara Weber, M.D.
President & CEO, Tango Therapeutics
Barbara is President and CEO of Tango Therapeutics, a biotechnology company she began building shortly after joining Third Rock Ventures…
Charlie Weatherspoon
Chairman and Co-founder
Chairman & Co-founder CEO and Co-Founder, Integral CFO Services LLC Charlie Weatherspoon co-founded The AIM HI Translational Research Fund (AIM-HI) and serves as the chairman...
Matt Tremblay, Ph.D.
Vice Chairman
Dr. Tremblay currently serves as the vice chairman of the board of AIM-HI. He is the chief operating officer of Scripps Research, as well as the chief operating officer for its drug discovery division...
Franklin Salisbury, Jr.
Co-founder and Director
Franklin Salisbury, Jr. has a background in economics, law and religion. Trained in resource economics at Yale, he has spent his career fostering innovative collaborations with experts...